CONMED Cash on Hand 2010-2024 | CNMD

CONMED cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
CONMED Annual Cash on Hand
(Millions of US $)
2023 $24
2022 $29
2021 $21
2020 $27
2019 $26
2018 $18
2017 $33
2016 $27
2015 $73
2014 $66
2013 $54
2012 $24
2011 $26
2010 $12
2009 $10
CONMED Quarterly Cash on Hand
(Millions of US $)
2024-09-30 $38
2024-06-30 $29
2024-03-31 $34
2023-12-31 $24
2023-09-30 $31
2023-06-30 $28
2023-03-31 $26
2022-12-31 $29
2022-09-30 $33
2022-06-30 $53
2022-03-31 $25
2021-12-31 $21
2021-09-30 $32
2021-06-30 $46
2021-03-31 $37
2020-12-31 $27
2020-09-30 $36
2020-06-30 $35
2020-03-31 $24
2019-12-31 $26
2019-09-30 $30
2019-06-30 $23
2019-03-31 $23
2018-12-31 $18
2018-09-30 $30
2018-06-30 $23
2018-03-31 $21
2017-12-31 $33
2017-09-30 $44
2017-06-30 $40
2017-03-31 $35
2016-12-31 $27
2016-09-30 $27
2016-06-30 $23
2016-03-31 $20
2015-12-31 $73
2015-09-30 $65
2015-06-30 $62
2015-03-31 $66
2014-12-31 $66
2014-09-30 $65
2014-06-30 $60
2014-03-31 $56
2013-12-31 $54
2013-09-30 $50
2013-06-30 $38
2013-03-31 $32
2012-12-31 $24
2012-09-30 $20
2012-06-30 $16
2012-03-31 $19
2011-12-31 $26
2011-09-30 $40
2011-06-30 $24
2011-03-31 $18
2010-12-31 $12
2010-09-30 $17
2010-06-30 $8
2010-03-31 $10
2009-12-31 $10
2009-09-30 $14
2009-06-30 $11
2009-03-31 $12
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.120B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.592B 20.08
Becton Dickinson (BDX) United States $66.029B 17.30
Cardinal Health (CAH) United States $28.625B 15.52
West Pharmaceutical Services (WST) United States $24.001B 49.02
Labcorp (LH) United States $19.121B 15.85
Cooper (COO) United States $18.649B 25.25
Align Technology (ALGN) United States $15.756B 30.15
Henry Schein (HSIC) United States $8.705B 16.58
Merit Medical Systems (MMSI) United States $5.724B 29.23
DENTSPLY SIRONA (XRAY) United States $3.717B 10.11
Patterson (PDCO) United States $2.725B 14.56
STAAR Surgical (STAA) United States $1.223B 45.13
Lifevantage (LFVN) United States $0.217B 28.93
Pro-Dex (PDEX) United States $0.159B 31.65